Carbapenemases producing gram-negative bacteria surveillance in Latin America and the caribbean: a retrospective observational study from 2015 to 2020
Marcelo Pillonetto, Priscila Lamb Wink, Roberto G. Melano, María Antonieta Jiménez-Pearson, Nancy Melgarejo Touchet, Sandra Yamile Saavedra, Débora Kulek, André Luiz de Abreu, Renata Tigulini de Souza Peral, Rogério Miorando, Hatim Sati, Genara Romero Thomas, Marcelo Galas, Pilar Ramón-Pardo, Carlos Roberto Veiga Kiffer, Ana Paula D’Alincourt Carvalho-Assef, Marinonio Ana Sílvia Scavacini, Costa-Nobre Daniela Testoni, Gonçalves Geiziane Aparecida, Jesus Ronaldo de, Rezende Thais F. T, Hormazabal Juan Carlos, Araya Pamela, Ovalle María Victoria, Duarte Carolina, Álvarez Tábata Elizondo, Hernández Priscilla Baltodano, Illnait María Teresa, Quiñones Dianelys, Salazar Carolina Satan, Román Karla, Grande Miguel, Boza Maria Luna, Herrera Andrés, Herrera Carmen Julia Mazariegos, Acuña Julissa Maria Avila, Lira Lissette Carolina Sandoval, Busignani Sofía, Brítez Mariel, Gavilan Ronnie, Flores-Leon Diana, Lopez Mariana, Caiata Leticia, Palmar Kerlin Vanessa Marcano, Noguera Carmen Isaura Ugarte, Torrico Elizabeth, Copa Helen
Abstract
Background: The rise of multidrug-resistant (MDR) bacteria represents a public health threat, with carbapenem resistance exacerbating this challenge. This study investigates carbapenemase-producing bacteria (CPB) across the Latin America and the Caribbean (LAC) region. Methods: complex (ABC). Findings: being the most frequent. Interpretation: . These findings underscore the urgent need for strengthened surveillance and public health interventions to combat carbapenemase-mediated resistance in the region. Funding: None.